Chronic hepatitis B virus infection
2018 · The Lancet · 543 citations
https://doi.org/10.1016/s0140-6736(18)31865-8
W
Wai‐Kay Seto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
456
Papers
12.3K
Citations
60
h-index
210
i10-index
Wai‐Kay Seto is an academic researcher from Chinese University of Hong Kong. The author has contributed to research in topics: Hepatitis B Virus Studies & Liver Disease Diagnosis and Treatment & Hepatitis C virus research. The author has an h-index of 60, co-authored 388 publications.
ORCID: 0000-0002-9012-313XPapers by this author
worksTreatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
2014 · Gut · 210 citations
https://doi.org/10.1136/gutjnl-2014-307237
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
2021 · Gastroenterology · 179 citations
https://doi.org/10.1053/j.gastro.2021.11.002
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
2022 · Journal of Hepatology · 115 citations
https://doi.org/10.1016/j.jhep.2022.01.007
Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
2022 · The Lancet Global Health · 114 citations
https://doi.org/10.1016/s2214-109x(21)00517-9
Reduction of Hepatitis B Surface Antigen Levels And Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients Receiving 10 Years of Nucleoside Analogue Therapy
2013 · Hepatology · 104 citations
https://doi.org/10.1002/hep.26376
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat